Related Experiment Video
Updated: May 12, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Erectile dysfunction in the cardiovascular patient
Charalambos Vlachopoulos1, Graham Jackson, Christodoulos Stefanadis
11st Department of Cardiology, Hippokration Hospital, Athens Medical School, Profiti Elia 24, Athens 14575, Greece. cvlachop@otenet.gr
Erectile dysfunction is a common sign of cardiovascular disease and an independent risk factor for future heart events. Addressing sexual health is crucial for cardiovascular risk assessment and management in men.
Area of Science:
- Cardiology
- Urology
- Sexual Medicine
Background:
- Erectile dysfunction (ED) is highly prevalent in patients with cardiovascular disease (CVD).
- ED significantly impacts quality of life and serves as an independent predictor of future cardiovascular events.
- A notable time lag exists between ED onset and cardiovascular event manifestation, offering a window for intervention.
Purpose of the Study:
- To review the intricate relationship between ED and CVD.
- To evaluate the implications of this connection for clinical practice.
- To propose management strategies for ED patients based on cardiovascular risk.
Main Methods:
- Literature review focusing on the link between ED and CVD.
- Analysis of ED as a cardiovascular risk marker.
- Development of clinical algorithms for ED management incorporating CVD risk assessment.
Main Results:
- ED is a critical early indicator of underlying vascular dysfunction.
- Comprehensive cardiovascular risk reduction strategies benefit both vascular health and sexual function.
- Sexual counseling enhances patient quality of life and treatment adherence.
Conclusions:
- Sexual function assessment should be integrated into routine cardiovascular risk evaluation for men.
- Holistic cardiovascular risk management improves ED and overall health outcomes.
- Structured approaches to ED management can mitigate future cardiovascular risks.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Coronary Artery Disease III: Clinical Manifestations